IAM TechIdentity and Access Management for GxP-regulated environments
In a GxP environment, deploying an access governance platform isn't the finish line — proving, with formal evidence, that it was validated correctly is. Most IAM consultancies have never touched that part of the process. We have.
Why this sector is different
Pharmaceutical and life sciences companies operate under GxP (Good Practice) regulations that most other industries never encounter — every system that touches regulated data or processes needs formal, documented validation, not just a working implementation. That changes what "done" means for an identity platform: it's not live until the validation evidence is complete too.
This is where generalist IAM delivery falls short. Designing the access model and integrations is only half the job — producing validation documentation that will actually survive an inspection is the other half, and it has to be built into the delivery from day one, not retrofitted afterwards.
The parts of IAM that matter most in pharma & life sciences
GxP Validation & Audit Readiness
Formal validation documentation delivered alongside the technical build — evidence that survives an inspection, not paperwork assembled after the fact.
See Compliance & Audit Readiness →Access Governance
Enterprise access governance built on platforms like SailPoint IdentityIQ, with lifecycle management and certification designed for a regulated environment.
See Access Governance →Strategy & Identity Acceleration
High- and low-level architecture design led by someone who has held the lead architect role directly, not handed off to a subcontractor.
See Strategy & Identity Acceleration →Enterprise system integration
Integration design across the systems that actually run the business — ServiceNow, Workday, Active Directory, and Microsoft Entra ID.
See Cloud Governance →Delivery experience, not promises
Years of domain experience
Advisory & consulting projects
Countries worldwide
Go-live implementations